0001615774-14-000028.txt : 20140813 0001615774-14-000028.hdr.sgml : 20140813 20140813165328 ACCESSION NUMBER: 0001615774-14-000028 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140813 DATE AS OF CHANGE: 20140813 EFFECTIVENESS DATE: 20140813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Holdings, Inc. CENTRAL INDEX KEY: 0001561551 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 990376434 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-222871 FILM NUMBER: 141038161 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE, STREET 2: BUILDING 400, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 674-1865 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE, STREET 2: BUILDING 400, 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: CERULEAN GROUP, INC. DATE OF NAME CHANGE: 20121102 D 1 primary_doc.xml X0707 D LIVE 0001561551 Enumeral Biomedical Holdings, Inc. ONE KENDALL SQUARE BUILDING 400, 4TH FLOOR CAMBRIDGE MA MASSACHUSETTS 02139 (617) 674-1865 DELAWARE Cerulean Group, Inc. CERULEAN GROUP, INC. Corporation true 2012 Arthur H. Tinkelenberg One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Chief Executive Officer, President and Director John J. Rydzewski One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Executive Chairman Derek Brand One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Vice President of Business Development and Secretary Anhco Nguyen One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Vice President of Research and Development Kevin Sarney One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Executive Officer Vice President of Finance, Chief Accounting Officer and Treasurer Daniel B. Wolfe One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Director Allan Rothstein One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Director Barry Buckland One Kendall Square Building 400, 4th Floor Cambridge MA MASSACHUSETTS 02139 Director Pharmaceuticals Decline to Disclose 06b false 2014-07-31 false true true true Common stock, warrants to purchase common stock and stock options true The Issuer entered into a definitive merger agreement with Enumeral Biomedical Corp. and Enumeral Acquisition Corp., dated as of July 31, 2014. 0 25150000 25150000 0 Represents aggregate value of the shares of the Issuer's common stock, warrants and options issued to shareholders of Enumeral Biomedical Corp. in connection with the merger. true 5 79 0 0 0 false Enumeral Biomedical Holdings, Inc. /s/ Arthur Tinkelenberg Arthur Tinkelenberg Chief Executive Officer 2014-08-12